King Acquires Meridian Medical Technologies
Business Review Editor
Abstract
King Pharmaceuticals to acquire Meridian Technologies for US$247.8 M in cash (US$44.50 per Meridian share). Meridian is a medical device and drug delivery company that develops and markets autoinjectors and pen like drug delivery devices e.g. EpiPen®.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.